Home › Compare › PTBRY vs ABBV
PTBRY yields 16.69% · ABBV yields 3.06%● Live data
📍 PTBRY pulled ahead of the other in Year 1
Combined, PTBRY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PTBRY + ABBV for your $10,000?
PT Bank Negara Indonesia (Persero) Tbk, together with its subsidiaries, provides various banking products and services in Indonesia, the United States, Europe, and Asia. The company offers current, savings, and money market accounts, and time deposit products. It also provides credit facilities for the purchase of houses, villas, apartments, condominiums, home shops, home offices, and land plots, as well as for construction/renovation, top-up, and refinancing; and pension loans. In addition, the company offers debit and credit cards; SMS, Internet, and phone banking services, as well as automated teller machines; treasury services; transactional banking products, such as payment, collection, liquidity, and information management services; small and long-term loans, which include working capital credit, investment credit, bank guarantee, local letter of credit, and letter of credit; and customer analysis and portfolio management services. Further, it provides facilities for foreign exchange services; investment products, such as government, retail, and company bonds; transaction derivatives; BNIFX, a web-based digital platform to conduct non-physical forex transactions directly with BNI treasury dealers; local currency settlement; and trade finance services, which include export and import LC and non-LC, standby letter of credit, bill collection financing, open account financing, and BNI Trade Online, a digital service to submit requests for trade transactions online. The company serves agriculture, telecommunication, food and beverage, oil and gas, mining, chemicals, construction, electricity, and wholesale and retail. As of December 31, 2021, the company operated 195 domestic branches, 1,097 sub-branches, and 874 other outlets, as well as 5 overseas branches located in Singapore, Hong Kong, Tokyo, London, and Seoul; and 1 representative office in New York. PT Bank Negara Indonesia (Persero) Tbk was founded in 1946 and is headquartered in Jakarta Pusat, Indonesia.
Full PTBRY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.